Qyuns Therapeutics Co (HKSE:02509) EV-to-EBITDA : -9.75 (As of Jun. 03, 2025)

Qyuns Therapeutics Co EV-to-EBITDA Chart

Competitive Comparison of Qyuns Therapeutics Co's EV-to-EBITDA

For the Biotechnology subindustry, Qyuns Therapeutics Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qyuns Therapeutics Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qyuns Therapeutics Co's EV-to-EBITDA falls into.

Qyuns Therapeutics Co EV-to-EBITDA Calculation

Qyuns Therapeutics Co's EV-to-EBITDA for today is calculated as:

Qyuns Therapeutics Co's current Enterprise Value is HK$2,518.8 Mil.
Qyuns Therapeutics Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-258.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qyuns Therapeutics Co  (HKSE:02509) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Qyuns Therapeutics Co's PE Ratio (TTM) for today is calculated as:

Qyuns Therapeutics Co's share price for today is HK$11.96.
Qyuns Therapeutics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-1.219.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Qyuns Therapeutics Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Qyuns Therapeutics Co Business Description